Role of SEREX-Defined Immunogenic Wild-Type Cellular Molecules in the Development of Tumor-Specific Immunity

Recognition of altered self-antigens in tumor cells by lymphocytes forms the basis for antitumor immune responses. The effector cells in most experimental tumor systems are CD8+T cells that recognize MHC class I binding peptides derived from molecules with altered expression in tumor cells. Although...

Ausführliche Beschreibung